Source Feed: The Globe and Mail
Author: Kelly Grant
Publication Date: March 29, 2025 - 10:30
Semaglutide, or Ozempic, reduces symptoms of feared diabetes’ complication, study finds
March 29, 2025
Semaglutide, the medication better known as Ozempic, reduces the symptoms of a condition that can lead to lower limb amputations in people with diabetes, according to a new study that reinforces the benefits of the popular drug beyond weight loss.The results of the clinical trial, which was co-led by a Canadian doctor, show that semaglutide improved quality of life and increased the distance that participants could walk without the debilitating calf cramping that is a hallmark of peripheral artery disease, or PAD.
Unpublished Newswire
When I was appointed Ottawa’s first-ever nightlife commissioner in June 2024, my role was clear: to implement the City of Ottawa's council-approved Nightlife Economy Action Plan, with a target completion by the end of 2026. But this is just the beginning: transforming a city’s nightlife is a marathon, not a sprint. It’s also a lot of detailed work at City Hall; it’s not just about attending events and going to parties. Read More
April 2, 2025 - 04:30 | Christina Spencer, Ottawa Citizen | Ottawa Citizen
As the federal election campaign picks up speed, the Citizen's Bruce Deachman has been asking Ottawa residents to share, in their own words, some experiences and thoughts on voting. Today: Brad Fisher of Sandy Hill explains what he thinks is the main election issue. Read More
April 2, 2025 - 04:00 | Bruce Deachman | Ottawa Citizen
The Canadian Forces says it is trying to work out problems with its reserve compensation system that has resulted in some part-time soldiers not being paid for their service. Read More
April 2, 2025 - 04:00 | David Pugliese, Ottawa Citizen | Ottawa Citizen
Comments
Be the first to comment